Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence.

导出 LinkOut

翻译打印收藏纠错

作者： Marco,Colizzi ^[1] ; Riccardo,Bortoletto ^[2] ; Chiara,Colli ^[1] ; Enrico,Bonomo ^[2] ; Daniele,Pagliaro ^[1] ; Elisa,Maso ^[1] ; Gianfranco,Di Gennaro ^[1] ; Matteo,Balestrieri ^[1]

作者单位： Unit of Psychiatry, Department of Medicine (DAME), University of Udine, Udine, Italy. ^[1] Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. ^[2] Department of Health Sciences, School of Medicine, University of Catanzaro Magna Graecia, Catanzaro, Italy. ^[3]

关键词 Alzheimer's disease Parkinson's disease acylethanolamines cannabinoids dementia immune response neurocognitive disorder

DOI 10.3389/fpsyt.2022.1038122

PMID 36387000

发布时间 2022-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in psychiatry

2022年13卷

1038122页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence.

Frontiers in psychiatry

相似文献

Frontiers in psychiatry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence.

Frontiers in psychiatry

相似文献

Frontiers in psychiatry

相关期刊

检索历史清除